Phase 1 Pulmonary Arterial Hypertension (PAH) trials recruiting now

All Pulmonary Arterial Hypertension (PAH) trials, every phase

Other phases for Pulmonary Arterial Hypertension (PAH)

Phase 1 Pulmonary Arterial Hypertension (PAH) trials

• A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy.
  NCT07593027 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 29 locations
• A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension
  NCT06872112 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Study of Intravenous ZMA001 in Healthy Subjects
  NCT05967299 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.